Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1

被引：0
|
作者：
Tsementzi, D. [1 ]
Buchwald, Z. S. [2 ]
Qiu, L. [3 ]
Khan, M. K. [1 ]
Konstantinidis, K. [4 ]
Bruner, D. W. [5 ]
Lin, J. Y., Jr. [6 ,7 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA
[5] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA
[6] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA
[7] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.969
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3552
引用
收藏
页码：E667 / E667
页数：1
相关论文
共 50 条
  • [1] Benefit with anti-PD-L1
    Diana Romero
    Nature Reviews Clinical Oncology, 2017, 14 : 71 - 71
  • [2] Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon Cancer
    Liu, Xuerun
    Wang, Luoyang
    Jing, Nan
    Jiang, Guoqiang
    Liu, Zheng
    MICROORGANISMS, 2020, 8 (02)
  • [3] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Jiming Chen
    Jie Yang
    Wenhui Wang
    Danfeng Guo
    Chengyan Zhang
    Shibo Wang
    Xinliang Lu
    Xiaofang Huang
    Pingli Wang
    Gensheng Zhang
    Jing Zhang
    Jianli Wang
    Zhijian Cai
    Cellular & Molecular Immunology, 2022, 19 : 1290 - 1301
  • [4] Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1
    Chen, Jiming
    Yang, Jie
    Wang, Wenhui
    Guo, Danfeng
    Zhang, Chengyan
    Wang, Shibo
    Lu, Xinliang
    Huang, Xiaofang
    Wang, Pingli
    Zhang, Gensheng
    Zhang, Jing
    Wang, Jianli
    Cai, Zhijian
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (11) : 1290 - 1301
  • [5] Hyperprogressive disease with anti-PD-1 and anti-PD-L1
    Brower, Vicki
    LANCET ONCOLOGY, 2016, 17 (12): : E527 - E527
  • [6] IMMUNOTHERAPY Benefit with anti-PD-L1
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (02) : 70 - 70
  • [7] Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies
    Philips, George K.
    Atkins, Michael
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 39 - 46
  • [8] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [9] Bilberry anthocyanin extracts enhance anti-PD-L1 efficiency by modulating gut microbiota
    Wang, Luoyang
    Jiang, Guoqiang
    Jing, Nan
    Liu, Xuerun
    Li, Qicheng
    Liang, Wei
    Liu, Zheng
    FOOD & FUNCTION, 2020, 11 (04) : 3180 - 3190
  • [10] Anti-PD-L1 Antibody and/or 17β-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model
    Song, Chin-Hee
    Kim, Nayoung
    Nam, Ryoung Hee
    Choi, Soo In
    Jang, Jae Young
    Choi, Jina
    Lee, Ha-Na
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 894 - 909
12345